Page 394 - Read Online

Page 12 of 13 Pisano et al. Vessel Plus 2020;4:33 I http://dx.doi.org/10.20517/2574-1209.2020.21

11. Gökalp AL, Takkenberg JJM. Decision-making in thoracic aortic aneurysm surgery-clinician and patient view. Semin Thorac Cardiovasc
Surg 2019;31:638-42.
12. Schepens MA. Editorial comment: surgery for aneurysms of the ascending aorta: keep it simple, safe and straightforward. Eur J
Cardiothorac Surg 2013;44:345.
13. Elefteriades JA, Farkas EA. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Cardiol
2010;55:841-57.
14. Elefteriades JA. Indications for aortic replacement. J Thorac Cardiovasc Surg 2010;140:S5-9; discussion S45-51.
15. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac
Surg 2002;74:S1877-80; discussion S1892-8.
16. Saeyeldin A, Zafar MA, Li Y, Tanweer M, Abdelbaky M, et al. Decision-making algorithm for ascending aortic aneurysm: Effectiveness
in clinical application? J Thorac Cardiovasc Surg 2019;157:1733-45.
17. Mokashi SA, Svensson LG. Guidelines for the management of thoracic aortic disease in 2017. Gen Thorac Cardiovasc Surg 2019;67:59-65.
18. Pape LA, Tsai TT, Isselbacher EM, Oh JK, O’gara PT, et al. International Registry of Acute Aortic Dissection (IRAD) Investigators.
Aortic diameter >or = 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute
Aorti Dissection (IRAD). Circulation 2007;116:1120-7.
19. Bassano C, Vacirca SR, Colella D, Bertoldo F, Pugliese M, et al. Is the diameter of the aorta a safe parameter for cardiac surgery
indication in aortic aneurysm? Proceeding of XXIX SICCH Meeting, 23-25 November 2018, Rome. J Cardiovasc Med 2018;19
8e-Supplement 2.
20. Svensson LG, Kim KH, Lytle BW, Cosgrove DM. Relationship of aortic cross-sectional area to height ratio and the risk of aortic
dissection in patients with bicuspid aortic valves. J Thorac Cardiovasc Surg 2003;126:892-3.
21. Williams DM, LePage MA, Lee DY. The dissected aorta. Part I. Early anatomic changes in an in vitro model. Radiology 1997;203:23-31.
22. Neri E, Barabesi L, Buklas D, Vricella LA, Benvenuti A, et al. Limited role of aortic size in the genesis of acute type A aortic dissection.
Eur J Cardiothorac Surg 2005;28:857-63.
23. Paruchuri V, Salhab KF, Kuzmik G, Gubernikoff G, Fang H, et al. Aortic size distribution in the general population: explaining the size
paradox in aortic dissection. Cardiology 2015;131:265-72.
24. Davies RR, Gallo A, Coady MA, Tellides G, Botta DM, et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic
aneurysms. Ann Thorac Surg 2006;81:169-77.
25. Zafar MA, Li Y, Rizzo JA, Charilaou P, Saeyeldin A, et al. Height alone, rather than body surface area, suffices for risk estimation in
ascending aortic aneurysm. J Thorac Cardiovasc Surg 2018;155:1938-50.
26. Acharya MN, Youssefi P, Soppa G, Valencia O, Nowell J, et al. Analysis of aortic area/height ratio in patients with thoracic aortic
aneurysm and Type A dissection. Eur J Cardiothorac Surg 2018;54:696-701.
27. Brownstein AJ, Kostiuk V, Ziganshin BA, Zafar MA, Kuivaniemi H, et al. Genes associated with thoracic aortic aneurysm and dissection:
2018 update and clinical implications. Aorta (Stamford) 2018;6:13-20.
28. Faggion Vinholo T, Brownstein AJ, Ziganshin BA, Zafar MA, Kuivaniemi H, et al. Genes associated with thoracic aortic aneurysm and
dissection: 2019 update and clinical implications. Aorta (Stamford) 2019;7:99-107.
29. Ostberg NP, Zafar MA, Ziganshin BA, Elefteriades JA. The genetics of thoracic aortic aneurysms and dissection: a clinical perspective.
Biomolecules 2020;10:182.
30. Ostberg NP, Zafar MA, Ziganshin BA, Elefteriades JA. The genetics of thoracic aortic aneurysms and dissection: a clinical perspective.
Biomolecules 2020;10:182.
31. Homme JL, Aubry MC, Edwards WD, Bagniewski SM, Shane Pankratz V, et al. Surgical pathology of the ascending aorta: a
clinicopathologic study of 513 cases. Am J Surg Pathol 2006;30:1159-68.
32. Grange T, Aubart M, Langeois M, Benarroch L, Arnaud P, et al. Quantifying the genetic basis of marfan syndrome clinical variability.
Genes (Basel) 2020;11:E574.
33. Ritelli M, Colombi M. Molecular genetics and pathogenesis of ehlers-danlos syndrome and related connective tissue disorders. Genes
(Basel) 2020;11:E547.
34. Fideler F, Magunia H, Grasshoff C. Cardiovascular risks in patients with loeys-dietz syndrome. Anesthesiology 2020;132:1554.
35. Zentner D, James P, Bannon P, Jeremy R. Familial aortopathies - state of the art review. Heart Lung Circ 2020;29:607-18.
36. Li T, Jing J, Sun L, Jiang B, Xin S, et al. TLR4 and MMP2 polymorphisms and their associations with cardiovascular risk factors in
susceptibility to aortic aneurysmal diseases. Biosci Rep 2019;39:BSR20181591.
37. Ruvolo G, Pisano C, Candore G, Lio D, Palmeri C, et al. Can the TLR-4-mediated signaling pathway be “a key inflammatory promoter
for sporadic TAA”? Mediators Inflamm 2014;2014:349476.
38. Balistreri CR, Ruvolo G, Lio D, Madonna R. Toll-like receptor-4 signaling pathway in aorta aging and diseases: “its double nature”. J
Mol Cell Cardiol 2017;110:38-53.
39. Pisano C, Balistreri CR, Ricasoli A, Ruvolo G. Cardiovascular disease in ageing: an overview on thoracic aortic aneurysm as an emerging
inflammatory disease. Mediators Inflamm 2017;2017:1274034.
40. Oosterhoff LA, Kruitwagen HS, van Wolferen ME, van Balkom BWM, Mokry M, et al. Characterization of endothelial and smooth
muscle cells from different canine vessels. Front Physiol 2019;10:101.
41. Bucci M, Vellecco V, Harrington L, Brancaleone V, Roviezzo F, et al. Cross-talk between toll-like receptor 4 (TLR4) and proteinase-
activated receptor 2 (PAR(2) ) is involved in vascular function. Br J Pharmacol 2013;168:411-20.
42. Romacho T, Vallejo S, Villalobos LA, Wronkowitz N, Indrakusuma I, et al. Soluble dipeptidyl peptidase-4 induces microvascular